February 18, 2026 · Form 4 insider transaction
Sorg Elaine K. bought 27,500 shares of Artiva Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
One-third of the shares vested following the grant date, with the remaining shares vesting monthly over an additional two years following February 18, 2026.